Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Collagen type VI alpha 4 pseudogene 1 (COL6A4P1) is a transcribed pseudogene located on chromosome 3. It represents the 5' end of a presumed human ortholog of the mouse gene encoding collagen VI alpha 4 chain protein, but in humans, the gene is disrupted by a chromosomal break and split into two separate pseudogenes (COL6A4P1 and COL6A4P2), resulting in nonfunctional fragments. No full-length open reading frame corresponding to a functional protein is present, and there is no evidence for translation of a complete protein[1][4][6][10]. Some studies suggest the truncated transcript may have a regulatory function, but its precise biological role remains unclear[1][5]. The gene is not considered a therapeutic target as it does not encode an active receptor, enzyme, or protein product[1][6][10]. There is some evidence of genetic variants in related sequences (DVWA SNPs) being associated with osteoarthritis risk, though the direct involvement of COL6A4P1 itself is not established[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen type VI alpha 4 pseudogene 1 (COL6A4P1).